On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...